SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmos (PARS)
An SI Board Since October 1998
Posts SubjectMarks Bans Symbol
1386 42 0 PARS
Emcee:  Dr. John M. de Castro Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
536 Dear Yosi: My semi-educated guess is that the list includes one or both of thDavid Israel-Rosen-2/24/1999
535 Apparently, this company is going to have to make $1 a share and start paying aLLCF-2/24/1999
534 There is a post on Yahoo that the short list for HU 211 is in. IT IS GREAT NEWSyosi s-2/23/1999
533 Well, HU-211, tamoxifen...I really was asking tongue-in-cheek, given the situatj_fir2-2/18/1999
532 <Any possibility PARS management is trying to avoid generating (wasting?) gLLCF-2/18/1999
531 I dreampt I was hanging out with or maybe even working for the Pharmos Corporatj_fir2-2/18/1999
530 Any possibility PARS management is trying to avoid generating (wasting?) good nj_fir2-2/18/1999
529 < So it indeed looks like the stock will continue to get pounded for a whileLLCF-2/18/1999
528 Tony, thanks for your response. It's clear from the earlier posting that twolfdog2-2/18/1999
527 Wolfdog- I took the pertinent phrases directly from the 10Q- I just did not feeTony van Werkhooven-2/18/1999
526 Tony, as I read the clauses that you have quoted, the conversion price whether wolfdog2-2/18/1999
525 Dow Jones upbeat on Pars: February 17, 1999 Dow Jones Newswires Israel&Merav-2/18/1999
524 Yes, seeing what you posted form the 8K certainly looks that way, I fired off aLLCF-2/17/1999
523 John: I did confirm this several months ago with the CFO. It is indeed a variabarnie h-2/17/1999
522 This is an interesting discussion. We might want to get clarification from the Dr. John M. de Castro-2/17/1999
521 David- the way I read it- The definition is: the conversion price is 90% of theTony van Werkhooven-2/17/1999
520 Tony, thanks digging up this information on the Castle Creek floorless convertiDr. John M. de Castro-2/17/1999
519 <If you read it differently, lets discuss it. > I read it that 1.) is tLLCF-2/17/1999
518 David- It appears to be a little more complicated than that. The following is Tony van Werkhooven-2/17/1999
517 <That equals $1.5 million left out of what was once $5 million. Based on thLLCF-2/17/1999
516 <Competition, many old (and cheap) generics that physicians rarely use.>LLCF-2/17/1999
515 Re: Convertible securities outstanding I asked PARS how much of the convertiblTony van Werkhooven-2/17/1999
514 Competition, many old (and cheap) generics that physicians rarely use. SteroidCacaito-2/17/1999
513 < Now let's see if the market is.> I think we'll have to play &qLLCF-2/17/1999
512 I like this: "Market share among opthalmologists also increased during thLLCF-2/17/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News